As an alternative, selective androgen receptor modulators (SARMs) have been intensively investigated for possible application in diseases with muscular weakness, although to date no SARM compounds have been launched as therapeutic agents for sarcopenia or cachexia [18]. Here, AR is linked to Cachexia.